STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial–Mesenchymal Transition

Table 1

STC2 gene expression and clinicopathological factors in 98 pancreatic cancer patients.

Characteristics	STC2 expression		p-value
	High (n=60)	Low (n=38)
Age (years, mean ± SD)	58.2 ± 5.7	60.3 ± 7.9	0.47
Sex (M/F)	38/22	20/18	0.29
Histology
Well	8	14	0.006
Moderate/poor	52	24
Tumor size
	5	10	0.016
≥3cm	55	28
Lymph node metastasis
Yes	38	15	0.02
No	22	23

The pancreatic carcinoma patients were divided into two groups based on the STC2 expression, and above the median level was identified as high expression groups and below the median level was classified as low expression group.